We used Swedish register data on both individual- and neighborhood-level to explore inequities in prostate cancer detection by relating the incidence rate of low-risk disease as a proxy for the diagnostic activity (PSA testing and subsequent examinations) to the incidence rate of advanced disease (including locally advanced and metastatic cancer at diagnosis). The gene discussed is KLK3; the disease is Familial prostate cancer.